Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache

Rescue medication consumption

Time frame: Baseline to cycle 6

Frequency and intensity of other hormone-related symptoms (bloating or swelling, breast tenderness, and nausea or vomiting) during cycle days 22 to 28

Time frame: Baseline to cycle 6

Prevalence of individual hormone-related symptoms during cycle days 1 to 21

Time frame: Baseline to cycle 6

Prevalence of individual hormone-related symptoms during hormone-free interval, i.e. cycle days 27+28 for EV/DNG capsules and cycle days 22 to 28 for the comparator

Time frame: Baseline, cycle 3 and cycle 6

Change in the average of the 3 highest VAS values of the hormone withdrawal associated symptoms pelvic pain or headache during cycle days 22 to 28 from baseline to cycle 3

Time frame: Baseline to cycle 3

Bleeding pattern and cycle control

Time frame: Throughout

QoL Questionnaires: Psychological General Well-Being Index (PGWBI), Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) and Clinical Global Index (CGI)

Time frame: Baseline, cycle 2 and cycle 5

AEs and SAEs. Concomitant medication. Vital signs (heart rate and blood pressure). Body weight